Overview
Panayiotis Manoli practices practicing medicine in Nicosia, Cyprus.
His clinical expertise encompasses Multiple Endocrine Neoplasia Type 2 and Multiple Endocrine Neoplasia.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Panayiotis Manoli
Is Panayiotis Manoli a top-rated expert for Multiple Endocrine Neoplasia Type 2?
MediFind is an objective health platform that identifies experts based on real-world data. Panayiotis Manoli is classified as an Experienced expert for Multiple Endocrine Neoplasia Type 2, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Panayiotis Manoli participate in research or clinical trials?
Yes. Panayiotis Manoli has published 9 articles and abstracts on conditions like Multiple Endocrine Neoplasia Type 2. You can view a list of Panayiotis Manoli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Multiple Endocrine NeoplasiaMr. Manoli isExperienced. Learn about Multiple Endocrine Neoplasia.
- Multiple Endocrine Neoplasia Type 2Mr. Manoli isExperienced. Learn about Multiple Endocrine Neoplasia Type 2.